In Cholesterol Drug Battle, Sanofi/Regeneron Jolt Prospects Of The Medicines Company And Esperion

Clearly, competition is the best way to contain the price of new, life-saving drugs.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NYSE:MRK NASDAQ:AMGN NASDAQ:REGN NYSE:SNY NASDAQ:MDCO Source Type: news